Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Axogen, Inc. Announces New Leadership Appointments
-
Howard Hughes Holdings Forms Special Committee to Evaluate Potential Take-Private
-
Emerita Intersects 11.4m of Massive Sulfide Grading 4.3% Copper, 48.31 g/t Silver and 1.85 g/t Gold at El Cura, Extending the Deposit at Depth
-
Synlogic Reports Second Quarter 2024 Financial Results
-
Amicus Therapeutics Announces Second Quarter 2024 Financial Results and Corporate Updates
-
Supremex Announces Results for the Second Quarter of 2024 and Maintains Dividend
-
Hydrofarm Holdings Group Announces Second Quarter 2024 Results
-
Americold Announces Second Quarter 2024 Results
-
EyePoint Pharmaceuticals to Present at the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference
-
Cerence Announces Third Quarter Fiscal Year 2024 Results
-
Engrail Therapeutics Appoints Paul Cayer as Chief Financial Officer and Saira Ramasastry to Board of Directors
-
Cognition Therapeutics Reports Financial Results for the Second Quarter 2024 and Provides Business and Clinical Update
-
Xometry Reports Second Quarter 2024 Results
-
Onex Appoints Sara Wechter to Board of Directors
-
Onex Reports Second Quarter 2024 Results
-
BiomX to Host Second Quarter 2024 Financial Results Conference Call and Webcast on August 15, 2024
-
ISS awarded 7-year contract with the UK Department of Work and Pensions (DWP) with expected annual value of DKK 1.2bn
-
Aura Biosciences Reports Second Quarter 2024 Financial Results and Business Highlights
-
Mikra Joins AcousticSheep for SleepPhones® x Serenity Giveaway
-
Altimmune Announces Second Quarter 2024 Financial Results and Provides a Business Update
-
Trevena Reports Second Quarter 2024 Results and Provides Business Update
-
Avadel Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2024 Financial Results
-
Monte Rosa Therapeutics Announces Second Quarter 2024 Financial Results and Provides Corporate Update
-
Beneficient Announces First Quarter Fiscal 2025 Earnings Release and Webcast
-
Cartesian Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
-
Capital City Bank Announces Ashley Leggett As Chief People Officer
-
Optinose Reports Second Quarter 2024 Financial Results and Recent Operational Highlights
-
The Tile Shop Reports Second Quarter 2024 Results
-
Nexxen Expands Vevo’s Programmatic Footprint Through New Partnership
-
Maybacks Global Entertainment and ZEASN Technology Private Ltd. Sign Global Licensing Agreement
-
Lifetime Brands, Inc. Reports Second Quarter 2024 Financial Results
-
Apellis and Sobi Announce Positive Topline Results from Phase 3 VALIANT Study of Pegcetacoplan in C3G and Primary IC-MPGN
-
Royalty Pharma Reports Second Quarter 2024 Results
-
Alphakek AI Expands to Base Network with Launch of $AIKEK Token
-
RYVYL Licenses its Payment Platform as a Service (“PPaaS”) to a U.S. National Payment Processor
-
Bio-Path Holdings to Announce Second Quarter 2024 Financial Results on August 15, 2024
-
Tecnoglass Reports Second Quarter 2024 Results
-
Autolus Therapeutics Reports Second Quarter 2024 Financial Results and Business Updates
-
Village Farms International Reports Q2/24 Results
-
Sterling Reports Second Quarter 2024 Results
-
Bitfarms Reports Second Quarter 2024 Results
-
ProMIS Neurosciences Announces Second Quarter 2024 Financial Results and Recent Highlights
-
Roivant Reports Financial Results for the First Quarter Ended June 30, 2024, and Provides Business Update
-
Axogen, Inc. Reports Second Quarter 2024 Financial Results
-
Zapata AI Announces Timing of its Second Quarter 2024 Results Conference Call
-
Kaltura Announces Financial Results for Second Quarter 2024
-
Plug Power Announces Key Developments and Strategic Milestones in Second Quarter 2024
-
Timeusb Releases 3 LiFePO4 Batteries at a Fresh Start
-
Cullinan Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial Results
-
Rapport Therapeutics Reports Second Quarter Financials and Provides Business Update
